Role of Pulse Oximetry in Examining
A pulse oximeter uses 2 diodes emitting light at 640 nm (red) and 940 nm (infrared), which are selectively absorbed by oxyhemoglobin and deoxyhemoglobin, respectively. Measurement of red and infrared light emerging from the tissue and calculation of their ratio are used to determine the oxygen saturation. Because visual recognition of cyanosis requires the presence of equal to or greater than 5 g/dL of deoxyhemoglobin, pulse oximetry allows detection of more subtle levels of desaturation. In addition, placement of 1 pulse oximeter probe on a preductal site (eg, right hand) and a second on a postductal site (eg, either foot) allows detection of ductal shunting, which occurs in 90% of cases of PPHN. With a threshold pre-to-postductal saturation difference of equal to or greater than 10%, oximetry can be used initially at diagnosis as well as to detect onset of shunting with patient agitation or clinical interventions (eg, suctioning). Unlike the labile oxygenation of the infant with PPHN, patients with cyanotic CHD have fixed low oxygen saturations. However, once prostaglandin E 1 infusion is initiated to maintain ductal patency in CHD lesions dependent on it for oxygenation, achievement and maintenance of higher saturations are readily noted. In PPHN associated with meconium aspiration syndrome, once the shunting resolves, the effects of parenchymal lung disease may persist for days to weeks. Consequently, every effort should be made to minimize barotrauma through "gentler" ventilation, use of high-frequency oscillatory ventilation to optimize lung volumes, and tolerance of lower pH (7.25-7.29) and higher PaCO 2 (50-60 mm Hg) in arterial blood.
Aside from its use in the early evaluation of cyanotic CHD, pulse oximetry can also play a key role in the detection of critical congenital heart disease (CCHD) in asymptomatic infants. CCHD, defined as lesions that require intervention in the first postnatal year for survival, account for approximately 25% of CHD cases, but the condition may not be evident initially because of incomplete transition from the fetal circulation (ie, elevated PVR and/or continued patency of the ductus arteriosus). Heart lesions with ductal-dependent pulmonary or systemic blood flow are most prominent in this category (Table 2) . Because fetal ultrasonography detects only about 50% of CCHDs, particularly lesions with single-ventricle configurations, its overall reliability is limited. Therefore, in the absence of effective screening, delays in diagnosis occur, leading to increased mortality, surgical morbidity, and neurodevelopmental disability. Echocardiography would be the gold standard for detection, but use of this modality in every baby would be impractical and costineffective. As a result, newborn screening with pulse oximetry has become the standard in an increasing number of states. Recently, screening has expanded from pulse oximetry on a single site to 2 measurements: one preductal and the second postductal. As shown in the algorithm (Figure) , a positive result of screening when performed at more than 24 hours of age consists of a single reading of less than 90% on any site OR 3 consecutive hourly readings of either 90% to 94% on any site or a difference of greater than 3% between upper and lower extremities. This methodology for CCHD screening provides sensitivity between 75% and 80%, specificity greater than 99%, positive predictive value of 26%, and negative predictive value of greater than 99%. Even with the fewer than 1% of neonates who have false-positive screening results for CCHD, echocardiography performed on these children may reveal other clinically relevant conditions, such as pulmonary hypertension. On this basis, CCHD screening is cost-effective; with $5 to $10 expended per child screened, detecting 1 case of CCHD before clinical deterioration offsets the cost of screening approximately 2,000 healthy newborns. Lesions that are the most difficult to detect include aortic outflow obstruction, which often presents later compared to other CCHDs. Further studies are required to determine the proper timing, if any, for CCHD screening in the NICU, where pulse oximetry is already being used for regular monitoring and other coexisting conditions (eg, prematurity, sepsis, and primary lung disease) and can complicate analysis.
Pulse oximetry has had a dramatic impact on neonatal care in the: 1) detection of subtle cyanosis (<5 g/dL deoxyhemoglobin), 2) differentiation of CHD and PPHN in the infant with acute cyanosis, and 3) detection of CCHD in the asymptomatic newborn. COMMENT: For those of us who felt like medieval torturers when jabbing the radial arteries of cyanotic neonates in a search for that arterial blood flow that seemed stubbornly resistant to our desperate efforts, the advent of pulse oximetry has been akin to the alchemist's dream of turning lead into gold. How much easier for us, and of course, more importantly, how much nicer for the children. Further, if we can't yet prevent the occurrence of critical congenital heart disease, at least we have a safe and efficient tool for identifying affected infants before they suffer irreversible harm, which is progress indeed! -Henry M. Adam, MD Associate Editor, In Brief
CME Quiz Corrections
An error was found in the CME quiz for the December 2015 article "Pain and Symptom Management in Pediatric Palliative Care" (Komatz K, Carter B. Pediatrics in Review. 2015; 36(12):257-534, doi: 10.1542/pir.36-12-527) . The correct answer for Question 4 should be "C. Ondansetron," with the following rationale: "Ondansetron, a serotonin 5-HT3 receptor antagonist, may be used in children older than 4 years to prevent postoperative nausea and vomiting, or that associated with chemotherapy." The quiz has been corrected. A correction notice has been posted with the online version of the article. The journal regrets the error.
In the CME quiz for the August 2016 review "Inflammatory Bowel Disease" (Shapiro JM, Subedi S, LeLeiko NS. Pediatrics in Review. 2016; 37(8):337-347, DOI: 10.1542 37(8):337-347, DOI: 10. /pir.2015 , the correct answer for Question 3 is "A. 
